Author Correction: Lisocabtagene maraleucel in follicular lymphoma: the phase 2 TRANSCEND FL study

Affiliations

• ¹ Centre Hospitalier Universitaire de Lille, Groupe de Recherche sur les formes Injectables et les Technologies Associées, Lille, France. franck.morschhauser@chu-lille.fr.
• ² Stanford University School of Medicine, Stanford, CA, USA.
• ³ University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore, MD, USA.
• ⁴ Memorial Sloan Kettering Cancer Center, New York, NY, USA.
• ⁵ Hospital Universitario de Salamanca, IBSAL, CIBERONC, Centro de Investigación del Cáncer-IBMCC (USAL-CSIC), Salamanca, Spain.
• ⁶ Hospital Virgen del Rocío, Instituto de Biomedicina de la Universidad de Sevilla, Seville, Spain.
• ⁷ Princess Margaret Cancer Centre, Toronto, Ontario, Canada.
• ⁸ Medical University of Vienna, Vienna, Austria.
• ⁹ Montpellier University Hospital Center, UMR CNRS 5535, Montpellier, France.
• ¹⁰ National Cancer Center Hospital, Tokyo, Japan.
• ¹¹ LMU University Hospital, München, Germany.
• ¹² Washington University School of Medicine in St. Louis, St. Louis, MO, USA.
• ¹³ Hôpital Lyon Sud, Lyon, France.
• ¹⁴ University College London Hospitals Biomedical Research Centre, London, UK.
• ¹⁵ Hokkaido University Hospital, Sapporo, Japan.
• ¹⁶ Azienda Socio Sanitaria Territoriale Papa Giovanni XXIII, Bergamo, Italy.
• ¹⁷ Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA, USA.
• ¹⁸ Universität zu Köln, Köln, Germany.
• ¹⁹ Hôpital Maisonneuve - Rosemont, Montreal, Quebec, Canada.
• ²⁰ Karolinska Institutet and University Hospital, Karolinska Comprehensive Cancer Center, Karolinska ATMP Center, Stockholm, Sweden.
• ²¹ Novant Health Cancer Institute, Charlotte, NC, USA.
• ²² UCLA Santa Monica Medical Centre, Santa Monica, CA, USA.
• ²³ University of Colorado Cancer Center, Aurora, CO, USA.
• ²⁴ Northwestern University Feinberg School of Medicine, Robert H. Lurie Comprehensive Cancer Center, Chicago, IL, USA.
• ²⁵ Department of Internal Medicine III, University Hospital, Ulm, Germany.
• ²⁶ Bristol Myers Squibb, Brisbane, CA, USA.
• ²⁷ Bristol Myers Squibb, Princeton, NJ, USA.
• ²⁸ Bristol Myers Squibb, Seattle, WA, USA.
• ²⁹ Bristol Myers Squibb, Boudry, Switzerland.
• ³⁰ The University of Texas MD Anderson Cancer Center, Houston, TX, USA.